3Teo PM,Leung SF,Lee WY, et al. Intracavitary brachytherapy significantly enhances local control of early T-stage nasopharyngeal carcinoma:the existence of a dose-tumor-control relationship above conventional tumorieidal dose [J]. Int J Radiat Oncol Biol Phys, 2000, 46(2):445-458.
4Talmi YP, Horowitz Z, Bedrin L, et al. Quality of life of nasopharyngeal carcinoma patients [J]. Cancer, 2002, 94 (4):1012-1017.
5Kam MK, Chau RM, Suen J, et al. Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation [J]. Int J Radiat Oncol Biol Phys, 2003, 56(1): 145-157.
6Munter MW, Karqer CP, Hoffner SG, et al. Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy [J]. Int J Radiat Oncol Biol Phys, 2004, 58(1):175-184.
7Chau RM, Teo PM, Choi PH, et al. Three-dimensional dosimetric evaluation of a conventional radiotherapy technique for treatment of nasophalyngeal carcinoma [J]. Radiother Oncol, 2001, 58(2):143-153.
8Waldron J, Tin MM, Keller A, et al. Limitation of conventional two dimensional radiation therapy planning in nasopharyngeal carcinoma [J]. Radiother Oncol, 2003, 68(2): 153-161.
9Parkin DM, Whelan SL, Ferlay J, et al. Cancer incidence in five continents [M]. IARC Scientific Publications Number 155,V01.8.Lyon: IARC Press, 2002. 534-536.
10Teo PM, Kwan WH, Lee WY, et al. Prognosticators determining survival subsequent to distant metastasis from nasopharyngeal carcinoma[J].Cancer, 1996,77(12):2423-2431.
